Pleiotropic Effect of Dronedarone Beyond Antiarrhythmic Agent: Reduction of Hypertrophy.
作者信息
Cha Jung-Joon
机构信息
Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
出版信息
Korean Circ J. 2024 Apr;54(4):187-188. doi: 10.4070/kcj.2024.0067.
Abstract
摘要
相似文献
1
Pleiotropic Effect of Dronedarone Beyond Antiarrhythmic Agent: Reduction of Hypertrophy.
Korean Circ J. 2024 Apr;54(4):187-188. doi: 10.4070/kcj.2024.0067.
2
Pharmacokinetic and pharmacodynamic profile of dronedarone , a new antiarrhythmic agent for the treatment of atrial fibrillation.
Expert Opin Drug Metab Toxicol. 2014 Dec;10(12):1751-64. doi: 10.1517/17425255.2014.974551. Epub 2014 Oct 28.
3
Pleiotropic effects of antiarrhythmic agents: dronedarone in the treatment of atrial fibrillation.
Clin Med Insights Cardiol. 2013 Aug 11;7:127-40. doi: 10.4137/CMC.S8445. eCollection 2013.
4
Inhibition of the NFATc4/ERK/AKT Pathway and Improvement of Thiol-Specific Oxidative Stress by Dronedarone Possibly Secondary to the Reduction of Blood Pressure in an Animal Model of Ventricular Hypertrophy.
Front Physiol. 2020 Aug 26;11:967. doi: 10.3389/fphys.2020.00967. eCollection 2020.
5
Dronedarone: a new antiarrhythmic agent.
Pharmacotherapy. 2010 Sep;30(9):904-15. doi: 10.1592/phco.30.9.904.
6
A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.
J Cardiovasc Pharmacol Ther. 2010 Dec;15(4 Suppl):24S-30S. doi: 10.1177/1074248410368276.
7
Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillation.
Curr Opin Cardiol. 2010 Jan;25(1):53-8. doi: 10.1097/HCO.0b013e32833354e4.
8
Dronedarone for atrial fibrillation have we expanded the antiarrhythmic armamentarium?
J Am Coll Cardiol. 2010 Apr 13;55(15):1569-76. doi: 10.1016/j.jacc.2009.10.071.
9
[Dronedarone].
Herzschrittmacherther Elektrophysiol. 2010 Dec;21(4):244-7. doi: 10.1007/s00399-010-0092-z.
10
Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
Circulation. 2009 Sep 29;120(13):1174-80. doi: 10.1161/CIRCULATIONAHA.109.875252. Epub 2009 Sep 14.
本文引用的文献
1
Dronedarone Attenuates Ang II-Induced Myocardial Hypertrophy Through Regulating SIRT1/FOXO3/PKIA Axis.
Korean Circ J. 2024 Apr;54(4):172-186. doi: 10.4070/kcj.2023.0197.
2
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.
3
Optimal Rhythm Control Strategy in Patients With Atrial Fibrillation.
Korean Circ J. 2022 Jul;52(7):496-512. doi: 10.4070/kcj.2022.0078.
4
Inhibition of the NFATc4/ERK/AKT Pathway and Improvement of Thiol-Specific Oxidative Stress by Dronedarone Possibly Secondary to the Reduction of Blood Pressure in an Animal Model of Ventricular Hypertrophy.
Front Physiol. 2020 Aug 26;11:967. doi: 10.3389/fphys.2020.00967. eCollection 2020.
5
Angiotensin-(1-9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129-3p/PKIA pathway.
Cell Death Differ. 2020 Sep;27(9):2586-2604. doi: 10.1038/s41418-020-0522-3. Epub 2020 Mar 9.
6
Dronedarone produces early regression of myocardial remodelling in structural heart disease.
PLoS One. 2017 Nov 21;12(11):e0188442. doi: 10.1371/journal.pone.0188442. eCollection 2017.
7
Pharmacokinetic and pharmacodynamic profile of dronedarone , a new antiarrhythmic agent for the treatment of atrial fibrillation.
Expert Opin Drug Metab Toxicol. 2014 Dec;10(12):1751-64. doi: 10.1517/17425255.2014.974551. Epub 2014 Oct 28.
8
Pleiotropic effects of dronedarone on ischemia/reperfusion injury in heart and brain.
Cardiovasc Drugs Ther. 2012 Jun;26(3):257-63. doi: 10.1007/s10557-012-6379-z.
9
Effect of dronedarone on cardiovascular events in atrial fibrillation.
N Engl J Med. 2009 Feb 12;360(7):668-78. doi: 10.1056/NEJMoa0803778.
Zotero 插件